Epidural hematoma after epidural steroid injection in a patient withholding enoxaparin per guidelines

被引：22

作者：

Ain, RJ ^{[1
]}

Vance, MB ^{[1
]}

机构：

[1] Virginia Mason Med Ctr, Seattle, WA 98101 USA

来源：

ANESTHESIOLOGY | 2005年 / 102卷 / 03期

关键词：

D O I：

10.1097/00000542-200503000-00048

中图分类号：

R614 [麻醉学];

学科分类号：

100217 ;

摘要：

引用

页码：701 / 703

页数：3

共 12 条

[1]

ABUHAJIR M, 1999, ANESTHESIOL CLIN N A, V17, P749

[2]

*AV PHARM, 2003, LOV PACK INS

[3] Prolonged anti-factor Xa level in a patient with moderate renal insufficiency receiving enoxaparin [J].

Bastani, B ;

Gonzalez, E .

AMERICAN JOURNAL OF NEPHROLOGY, 2002, 22 (04) :403-404

[4] Influence of patient characteristics and renal function on factor Xa inhibition pharmacokinetics and pharmacodynamics after enoxaparin administration in non-ST-segment elevation acute coronary syndromes [J].

Becker, RC ;

Spencer, FA ;

Gibson, M ;

Rush, JE ;

Sanderink, G ;

Murphy, SA ;

Ball, SP ;

Antman, EM .

AMERICAN HEART JOURNAL, 2002, 143 (05) :753-759

[5] The pharmacokinetics of subcutaneous enoxaparin in end-stage renal disease [J].

Brophy, DF ;

Wazny, LD ;

Gehr, TWB ;

Comstock, TJ ;

Venitz, J .

PHARMACOTHERAPY, 2001, 21 (02) :169-174

[6] Correlation of antifactor Xa concentrations with renal function in patients on enoxaparin [J].

Chow, SL ;

Zammit, K ;

West, K ;

Dannenhoffer, M ;

Lopez-Candales, A .

JOURNAL OF CLINICAL PHARMACOLOGY, 2003, 43 (06) :586-590

[7]

FOLLEA G, 1986, HAEMOSTASIS, V16, P141

[8] LOW-MOLECULAR-WEIGHT HEPARIN HALF-LIFE IS PROLONGED IN HEMODIALYZED PATIENTS [J].

GOUDABLE, C ;

THAT, HT ;

DAMANI, A ;

DURAND, D ;

CARANOBE, C ;

SIE, P ;

BONEU, B .

THROMBOSIS RESEARCH, 1986, 43 (01) :1-5

[9] Regional Anesthesia in the anticoagulated patient: Defining the risks (the Second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation) [J].

Horlocker, TT ;

Wedel, DJ ;

Benzon, H ;

Brown, DL ;

Enneking, FK ;

Heit, JA ;

Mulroy, MF ;

Rosenquist, RW ;

Rowlingson, J ;

Tryba, M ;

Yuan, CS .

REGIONAL ANESTHESIA AND PAIN MEDICINE, 2003, 28 (03) :172-197

[10] Pharmacokinetics and pharmacodynamics of the prophylactic dose of enoxaparin once daily over 4 days in patients with renal impairment [J].

Sanderink, GJCM ;

Guimart, CG ;

Ozoux, ML ;

Jariwala, NU ;

Shukla, UA ;

Boutouyrie, BX .

THROMBOSIS RESEARCH, 2002, 105 (03) :225-231

← 1 2 →